Neuralink's First Patient Speaks, and How to Invest in SpaceX
Listen now
Description
Last week, Bloomberg Businessweek published an exclusive look at Noland Arbaugh, the first person to get Elon Musk’s Neuralink technology implanted in his head. Our own Ashlee Vance spent time with Arbaugh, who lives with his parents and (as you’ll hear) some vocal farm animals. Vance joins us to talk about what he learned from the first patient in Neuralink’s inaugural clinical trial. He is joined by Bloomberg’s Sarah McBride to give a full picture on what it all means. Plus, we talk to markets reporter Kiel Porter and space reporter Loren Grush about all of the action around SpaceX stock—which is kind of interesting since it’s still a private company.  See omnystudio.com/listener for privacy information.
More Episodes
When Donald Trump claimed victory, early in the morning of Nov. 6, he did so not only for himself, his campaign staff and the voters who backed him–but also for the billionaire industrialist and media mogul who’d become his most unlikely supporter. “A star is born: Elon,” Trump said, his mouth...
Published 11/22/24
Published 11/22/24
Does money speak? And if so, what is it saying about Elon Musk and Donald Trump? In this episode of Elon, Inc., the panel—host David Papadopoulos, Elon Musk reporter Dana Hull, social media reporter Kurt Wagner and Bloomberg Businessweek senior writer Max Chafkin—consider how Musk has benefited...
Published 11/19/24